Blocking HIV replication by targeting Tat protein (Q44111908)

29 November 2017

title

Blocking HIV replication by targeting Tat protein (English)

1 reference

29 November 2017

Hamy F

1 reference

29 November 2017

Gelus N

1 reference

29 November 2017

Zeller M

1 reference

29 November 2017

Lazdins JL

1 reference

29 November 2017

Bailly C

1 reference

29 November 2017

Klimkait T

1 reference

29 November 2017

publication date

1 September 2000

1 reference

29 November 2017

published in

Chemistry and Biology

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

669-676

1 reference

Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

Rational optimization of a HIV-1 Tat inhibitor: rapid progress on combinatorial lead structures

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

Dissecting the mode of action of various HIV-inhibitor classes in a stable cellular system

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900012-0

7 January 2021

10.1016/S1074-5521(00)00012-0

Identifiers

DOI

1 reference

29 November 2017

1 reference